These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 6320685)
101. Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association. Vegni F; D'Alessandris N; Santoro A; Angelico G; Scaglione G; Carlino A; Arciuolo D; Valente M; Sfregola S; Natale M; Sanchez AM; Masciullo V; Zannoni GF; Mulè A J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373937 [TBL] [Abstract][Full Text] [Related]
102. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review. Lei T; Shi YQ; Chen TB Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820 [TBL] [Abstract][Full Text] [Related]
103. Mixed primary mucinous cystadenocarcinoma and invasive ductal carcinoma of the breast: a case report and literature review. Zuo C; Xie J Transl Cancer Res; 2022 Dec; 11(12):4455-4464. PubMed ID: 36644191 [TBL] [Abstract][Full Text] [Related]
104. Invasive cystic hypersecretory carcinoma of the breast. Chitti S; Misra S; Ahuja A; Gupta N; Yelamanchi R Autops Case Rep; 2022; 12():e2021375. PubMed ID: 35574044 [TBL] [Abstract][Full Text] [Related]
105. Cystic hypersecretory ductal carcinoma (CHDC): a rare distinctive variant of ductal carcinoma. DiPasquale A; Peiris L; Silverman S BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34289997 [TBL] [Abstract][Full Text] [Related]
106. Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature. Wang X; Li Y; Zhao P; Jia H; Dong X; Zhang L; Wang C Int J Clin Exp Pathol; 2020; 13(10):2562-2568. PubMed ID: 33165376 [TBL] [Abstract][Full Text] [Related]
107. Mammary synchronous mucinous cystadenocarcinoma and columnar cell mucinous carcinoma: a case report. Sun M; Su S; Liu Q; Li Q; Wang K Int J Clin Exp Pathol; 2020; 13(9):2381-2386. PubMed ID: 33042347 [TBL] [Abstract][Full Text] [Related]
108. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature. Sun J; Wang X; Wang C BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638 [TBL] [Abstract][Full Text] [Related]
109. Mucinous breast carcinoma with tall columnar cells. Tsoukalas N; Kiakou M; Tolia M; Kostakis ID; Galanopoulos M; Nakos G; Tryfonopoulos D; Kyrgias G; Koumakis G Ann R Coll Surg Engl; 2018 May; 100(5):e132-e135. PubMed ID: 29658333 [TBL] [Abstract][Full Text] [Related]
110. Mucinous cystadenocarcinoma of the breast: the challenge of diagnosing a rare entity. Koufopoulos N; Goudeli C; Syrios J; Filopoulos E; Khaldi L Rare Tumors; 2017 Oct; 9(3):7016. PubMed ID: 29081926 [TBL] [Abstract][Full Text] [Related]
111. Invasive Cystic Hypersecretory Carcinoma of Breast: A Rare and Under Diagnosed Variant of Ductal Carcinoma. Sahoo N; Mishra P; Patra S; Sasmal PK J Clin Diagn Res; 2017 Jun; 11(6):ED16-ED17. PubMed ID: 28764181 [TBL] [Abstract][Full Text] [Related]
112. Thyroidisation of breast - An intriguing entity. Manoj MG; Popli V Med J Armed Forces India; 2015 Oct; 71(4):402-4. PubMed ID: 26663974 [No Abstract] [Full Text] [Related]
113. Invasive cystic hypersecretory carcinoma of the breast: a case report. Liu J; Yang W; Wu X; Hu X Int J Clin Exp Pathol; 2015; 8(6):7499-502. PubMed ID: 26261660 [TBL] [Abstract][Full Text] [Related]
114. lnvasive cystic hypersecretory carcinoma of the breast associated with papillary pattern: a rare and poorly recognised variant of ductal carcinoma of the breast. Gupta P; Dhingra S; Musa O; Srivastava A Ecancermedicalscience; 2014; 8():477. PubMed ID: 25435905 [TBL] [Abstract][Full Text] [Related]
115. Primary mucinous cystadenocarcinoma of the breast with endocervical-like mucinous epithelium. Lin DL; Hu JL; Shao SH; Sun DM; Wang JG Breast Care (Basel); 2013 Dec; 8(6):445-7. PubMed ID: 24550753 [TBL] [Abstract][Full Text] [Related]
116. Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: case report and literature review. Liong YV; Hong GS; Teo JG; Lim GH World J Surg Oncol; 2013 Aug; 11(1):179. PubMed ID: 23924035 [TBL] [Abstract][Full Text] [Related]
117. Ductal carcinoma in situ: what the pathologist needs to know and why. Bane A Int J Breast Cancer; 2013; 2013():914053. PubMed ID: 23476791 [TBL] [Abstract][Full Text] [Related]
118. Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma. Kim SE; Park JH; Hong S; Koo JS; Jeong J; Jung WH Korean J Pathol; 2012 Dec; 46(6):611-6. PubMed ID: 23323116 [TBL] [Abstract][Full Text] [Related]
119. Cystic hypersecretory ductal carcinoma of the breast: a rare cause of cystic breast mass. Song SW; Whang IY; Chang ED Jpn J Radiol; 2011 Nov; 29(9):660-2. PubMed ID: 21956373 [TBL] [Abstract][Full Text] [Related]
120. Measurement of human epidermal growth factor receptor type-2 extracellular domain and cancer antigen 15-3 levels in needle washout fluid: a potential adjunct to the cytological diagnosis of breast cancer. Ichihara S; Moritani S; Hasegawa M; Shiraiwa M; Oiwa M; Endo T; Kato A; Hayashi T; Sato Y; Saito A Virchows Arch; 2011 May; 458(5):547-59. PubMed ID: 21437720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]